HCAR2 is the receptor target through which the important ketone body, β-hydroxybutyrate (BHB), and the active metabolite of the multiple sclerosis drug dimethyl-fumarate mediate their anti-inflammatory actions1,2. This evidence concerns the gene HCAR2 and multiple sclerosis.